Italian radiopharmaceutical firm Bracco last month signed an agreement with Caffaro, the lead company of Italian firm Snia Group’s Chemical and Energy sector. The agreement allows Bracco to build a new plant on the site of Industrie Chimiche Caffaro
Italian radiopharmaceutical firm Bracco last month signed an agreement with Caffaro, the lead company of Italian firm Snia Groups Chemical and Energy sector. The agreement allows Bracco to build a new plant on the site of Industrie Chimiche Caffaro in Torviscosa. The plant will manufacture Braccos imaging contrast media products, and Bracco will use the raw materials, utilities, facilities, and services already available at the site. The plant will eventually employ approximately 100 people.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.